Cargando…
‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection
BACKGROUND: The prevalence of nontuberculous mycobacterial (NTM) disease is rising. An understanding of known risk factors for disease sheds light on the immunological and physical barriers to infection, and how and why they may be overcome. This review focuses on human NTM infection, supported by e...
Autores principales: | Lake, M. Alexandra, Ambrose, Lyn R., Lipman, Marc C. I., Lowe, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806462/ https://www.ncbi.nlm.nih.gov/pubmed/27007918 http://dx.doi.org/10.1186/s12916-016-0606-6 |
Ejemplares similares
-
Why cure, why now?
por: Kuritzkes, Daniel R
Publicado: (2017) -
Why Cancer & Metabolism? Why now?
por: Van Dang, Chi, et al.
Publicado: (2013) -
Mentoring: Why now?
por: Saw, Mabel, et al.
Publicado: (2021) -
AEGIS, the Virtual European Genebank: Why It Is Such a Good Idea, Why It Is Not Working and How It Could Be Improved
por: van Hintum, Theo, et al.
Publicado: (2021) -
Why has epidemiology not (yet) succeeded in identifying the origin of the asthma epidemic?
por: Antó, Josep M, et al.
Publicado: (2023)